Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 11092-1-AP - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#11092-1-AP, RRID:AB_2082254
- Product name
- CLK2 antibody
- Antibody type
- Polyclonal
- Description
- CLK2 antibody (Cat. #11092-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references CLK2-SOX3 combination promotes choroidal neovascularization by SGLT1 inducing endothelial cell metabolic reprogramming.
Targeting ALDOA to modulate tumorigenesis and energy metabolism in retinoblastoma.
A novel selenium nanocomposite modified by AANL inhibits tumor growth by upregulating CLK2 in lung cancer.
Chromatin binding protein HMGN1 promotes HBV cccDNA transcription and replication by regulating the phosphorylation of histone 3.
RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker.
Zou R, Wu X, Chen H, Yuan F, Yuan Y
Cellular signalling 2025 Sep;133:111865
Cellular signalling 2025 Sep;133:111865
Targeting ALDOA to modulate tumorigenesis and energy metabolism in retinoblastoma.
Wang Y, Tang J, Liu Y, Zhang Z, Zhang H, Ma Y, Wang X, Ai S, Mao Y, Zhang P, Chen S, Li J, Gao Y, Cheng C, Li C, Su S, Lu R
iScience 2024 Sep 20;27(9):110725
iScience 2024 Sep 20;27(9):110725
A novel selenium nanocomposite modified by AANL inhibits tumor growth by upregulating CLK2 in lung cancer.
Zhang Y, Chen Y, Wang B, Cai Y, Zhang M, Guo X, Wu A, Wang W, Liu N, Wang X, Gong Y, Pan J, Jin Y
Bioorganic chemistry 2024 Jul;148:107459
Bioorganic chemistry 2024 Jul;148:107459
Chromatin binding protein HMGN1 promotes HBV cccDNA transcription and replication by regulating the phosphorylation of histone 3.
Ming T, Yuting L, Meiling D, Shengtao C, Jihua R, Hui Z, Wanjin C, Dian L, Tingting G, Juan C, Zhenzhen Z
Antiviral research 2024 Jan;221:105796
Antiviral research 2024 Jan;221:105796
RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker.
Jin Y, Cao B, Zhang M, Zhan Q, Herman JG, Yu M, Guo M
Genes & cancer 2015 May;6(5-6):231-40
Genes & cancer 2015 May;6(5-6):231-40
No comments: Submit comment
No validations: Submit validation data